TY -的A2田中大友盟——Grubnik,亚历山德拉盟——Ramdas Yastira AU -范德马瑞医生,Barend盟——Nayler西蒙AU - Benn,卡罗尔·安·AU -拉波波特,伯纳德。l . PY - 2022 DA - 2022/05/31 TI -南非乳房Implant-Associated间变性大细胞淋巴瘤:临床表现和6年随访SP - 4162832六世- 2022 AB -隆胸是最常见的外科手术对女性在全球范围内,有1795551例是因2019年执行。乳房implant-associated间变性大细胞淋巴瘤(BIA-ALCL)非常罕见,2020年1月就有733起病例。在南非,有每年不到4000隆胸手术。这种情况下提出的第一个病例报告文档南非妇女诊断出患有BIA-ALCL。患者是一位61岁的妇女的乳房护理中心咨询卓越2015年在约翰内斯堡。她之前的历史与后续的双边增强乳房成形术植入交换。患者periprosthetic液体似的质量增强左边乳房。愿望似的质量流体CD45阳性,CD30,和CD68和消极CD20, ALK-1 BIA-ALCL的象征。外科治疗包括双边移出,完成capsulectomies,双边乳房固定术。宏观检验的左胸capsulectomy证明纤维结缔组织。 The histological examination of the tumor showed extensive areas of broad coagulative necrosis with foamy histiocytes. Immunohistochemistry examination of this tumor showed CD3-, CD20-, and ALK-1-negative and CD30- and CD68-positive stains. PCR analysis for T-cell clonality showed monoclonal T-cell expansion. These findings confirm the presence of BIA-ALCL. The patient recovered well after surgery and did not require adjuvant therapy. A patient with a confirmed diagnosis of BIA-ALCL was successfully treated with explantation and complete capsulectomy. She was followed up regularly for six years, and the patient remains well and in remission. SN - 2090-6706 UR - https://doi.org/10.1155/2022/4162832 DO - 10.1155/2022/4162832 JF - Case Reports in Oncological Medicine PB - Hindawi KW - ER -